nodes	percent_of_prediction	percent_of_DWPC	metapath
Naphazoline—NISCH—Podofilox—Etoposide—urinary bladder cancer	0.0634	1	CbGdCrCtD
Naphazoline—NISCH—prostate gland—urinary bladder cancer	0.0396	0.132	CbGeAlD
Naphazoline—Ocular discomfort—Methotrexate—urinary bladder cancer	0.0292	0.0459	CcSEcCtD
Naphazoline—NISCH—smooth muscle tissue—urinary bladder cancer	0.028	0.0933	CbGeAlD
Naphazoline—NISCH—urethra—urinary bladder cancer	0.0265	0.0882	CbGeAlD
Naphazoline—Hyperglycaemia—Valrubicin—urinary bladder cancer	0.0251	0.0395	CcSEcCtD
Naphazoline—Lacrimation—Fluorouracil—urinary bladder cancer	0.0217	0.034	CcSEcCtD
Naphazoline—NISCH—vagina—urinary bladder cancer	0.0195	0.065	CbGeAlD
Naphazoline—ADRA1A—prostate gland—urinary bladder cancer	0.019	0.0631	CbGeAlD
Naphazoline—ADRA2C—prostate gland—urinary bladder cancer	0.0181	0.0602	CbGeAlD
Naphazoline—Drowsiness—Mitomycin—urinary bladder cancer	0.0171	0.0269	CcSEcCtD
Naphazoline—Discomfort—Valrubicin—urinary bladder cancer	0.0163	0.0257	CcSEcCtD
Naphazoline—ADRA2C—seminal vesicle—urinary bladder cancer	0.0153	0.0509	CbGeAlD
Naphazoline—ADRA2A—prostate gland—urinary bladder cancer	0.0144	0.048	CbGeAlD
Naphazoline—ADRA1A—epithelium—urinary bladder cancer	0.0139	0.0464	CbGeAlD
Naphazoline—Lacrimation increased—Fluorouracil—urinary bladder cancer	0.0138	0.0217	CcSEcCtD
Naphazoline—Erythema—Mitomycin—urinary bladder cancer	0.0134	0.021	CcSEcCtD
Naphazoline—ADRA1A—renal system—urinary bladder cancer	0.0129	0.043	CbGeAlD
Naphazoline—NISCH—lymph node—urinary bladder cancer	0.0126	0.0421	CbGeAlD
Naphazoline—Vision blurred—Mitomycin—urinary bladder cancer	0.0126	0.0198	CcSEcCtD
Naphazoline—ADRA2C—renal system—urinary bladder cancer	0.0123	0.041	CbGeAlD
Naphazoline—ADRA2A—seminal vesicle—urinary bladder cancer	0.0122	0.0406	CbGeAlD
Naphazoline—ADRA2C—urethra—urinary bladder cancer	0.0121	0.0403	CbGeAlD
Naphazoline—Hypertension—Mitomycin—urinary bladder cancer	0.0116	0.0182	CcSEcCtD
Naphazoline—Asthenia—Valrubicin—urinary bladder cancer	0.0114	0.0179	CcSEcCtD
Naphazoline—Discomfort—Mitomycin—urinary bladder cancer	0.0113	0.0177	CcSEcCtD
Naphazoline—Lacrimation—Epirubicin—urinary bladder cancer	0.0105	0.0166	CcSEcCtD
Naphazoline—Dizziness—Valrubicin—urinary bladder cancer	0.0105	0.0165	CcSEcCtD
Naphazoline—Headache—Valrubicin—urinary bladder cancer	0.00993	0.0156	CcSEcCtD
Naphazoline—Lacrimation—Doxorubicin—urinary bladder cancer	0.00975	0.0153	CcSEcCtD
Naphazoline—Somnolence—Mitomycin—urinary bladder cancer	0.00971	0.0153	CcSEcCtD
Naphazoline—ADRA2A—urethra—urinary bladder cancer	0.00965	0.0321	CbGeAlD
Naphazoline—Keratitis—Epirubicin—urinary bladder cancer	0.00956	0.015	CcSEcCtD
Naphazoline—Nausea—Valrubicin—urinary bladder cancer	0.00942	0.0148	CcSEcCtD
Naphazoline—Redness—Epirubicin—urinary bladder cancer	0.00918	0.0144	CcSEcCtD
Naphazoline—ADRA2C—vagina—urinary bladder cancer	0.00892	0.0297	CbGeAlD
Naphazoline—Keratitis—Doxorubicin—urinary bladder cancer	0.00884	0.0139	CcSEcCtD
Naphazoline—Hyperglycaemia—Thiotepa—urinary bladder cancer	0.00871	0.0137	CcSEcCtD
Naphazoline—Redness—Doxorubicin—urinary bladder cancer	0.0085	0.0134	CcSEcCtD
Naphazoline—ADRA2A—female reproductive system—urinary bladder cancer	0.00787	0.0262	CbGeAlD
Naphazoline—Asthenia—Mitomycin—urinary bladder cancer	0.00784	0.0123	CcSEcCtD
Naphazoline—Hyperglycaemia—Gemcitabine—urinary bladder cancer	0.00733	0.0115	CcSEcCtD
Naphazoline—Eye disorder—Thiotepa—urinary bladder cancer	0.00722	0.0114	CcSEcCtD
Naphazoline—Dizziness—Mitomycin—urinary bladder cancer	0.00722	0.0114	CcSEcCtD
Naphazoline—ADRA2A—vagina—urinary bladder cancer	0.00712	0.0237	CbGeAlD
Naphazoline—Sweating—Gemcitabine—urinary bladder cancer	0.00694	0.0109	CcSEcCtD
Naphazoline—Headache—Mitomycin—urinary bladder cancer	0.00684	0.0108	CcSEcCtD
Naphazoline—Erythema—Thiotepa—urinary bladder cancer	0.00673	0.0106	CcSEcCtD
Naphazoline—Lacrimation increased—Epirubicin—urinary bladder cancer	0.00673	0.0106	CcSEcCtD
Naphazoline—Tension—Thiotepa—urinary bladder cancer	0.0066	0.0104	CcSEcCtD
Naphazoline—Nervousness—Thiotepa—urinary bladder cancer	0.00654	0.0103	CcSEcCtD
Naphazoline—Nausea—Mitomycin—urinary bladder cancer	0.00649	0.0102	CcSEcCtD
Naphazoline—Vision blurred—Thiotepa—urinary bladder cancer	0.00634	0.00997	CcSEcCtD
Naphazoline—Lacrimation increased—Doxorubicin—urinary bladder cancer	0.00622	0.00978	CcSEcCtD
Naphazoline—Hypertension—Thiotepa—urinary bladder cancer	0.00581	0.00913	CcSEcCtD
Naphazoline—ADRA2C—lymph node—urinary bladder cancer	0.00577	0.0192	CbGeAlD
Naphazoline—Eye disorder—Cisplatin—urinary bladder cancer	0.00566	0.0089	CcSEcCtD
Naphazoline—Erythema—Gemcitabine—urinary bladder cancer	0.00566	0.0089	CcSEcCtD
Naphazoline—Erythema—Fluorouracil—urinary bladder cancer	0.00557	0.00875	CcSEcCtD
Naphazoline—Erythema—Cisplatin—urinary bladder cancer	0.00528	0.00829	CcSEcCtD
Naphazoline—Vision blurred—Fluorouracil—urinary bladder cancer	0.00525	0.00824	CcSEcCtD
Naphazoline—Eye disorder—Etoposide—urinary bladder cancer	0.00519	0.00816	CcSEcCtD
Naphazoline—Eye pain—Epirubicin—urinary bladder cancer	0.00498	0.00783	CcSEcCtD
Naphazoline—Vision blurred—Cisplatin—urinary bladder cancer	0.00497	0.00782	CcSEcCtD
Naphazoline—Hypertension—Gemcitabine—urinary bladder cancer	0.00489	0.00768	CcSEcCtD
Naphazoline—Somnolence—Thiotepa—urinary bladder cancer	0.00488	0.00767	CcSEcCtD
Naphazoline—Discomfort—Gemcitabine—urinary bladder cancer	0.00476	0.00748	CcSEcCtD
Naphazoline—Discomfort—Fluorouracil—urinary bladder cancer	0.00468	0.00736	CcSEcCtD
Naphazoline—Eye pain—Doxorubicin—urinary bladder cancer	0.00461	0.00725	CcSEcCtD
Naphazoline—ADRA2A—lymph node—urinary bladder cancer	0.0046	0.0153	CbGeAlD
Naphazoline—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.00447	0.00702	CcSEcCtD
Naphazoline—Discomfort—Cisplatin—urinary bladder cancer	0.00444	0.00698	CcSEcCtD
Naphazoline—Hypertension—Etoposide—urinary bladder cancer	0.00417	0.00656	CcSEcCtD
Naphazoline—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.00416	0.00654	CcSEcCtD
Naphazoline—Somnolence—Gemcitabine—urinary bladder cancer	0.00411	0.00646	CcSEcCtD
Naphazoline—Discomfort—Etoposide—urinary bladder cancer	0.00407	0.00639	CcSEcCtD
Naphazoline—Somnolence—Fluorouracil—urinary bladder cancer	0.00404	0.00635	CcSEcCtD
Naphazoline—Asthenia—Thiotepa—urinary bladder cancer	0.00394	0.00619	CcSEcCtD
Naphazoline—Hyperhidrosis—Etoposide—urinary bladder cancer	0.00381	0.00599	CcSEcCtD
Naphazoline—Drowsiness—Methotrexate—urinary bladder cancer	0.00371	0.00582	CcSEcCtD
Naphazoline—Dizziness—Thiotepa—urinary bladder cancer	0.00363	0.00571	CcSEcCtD
Naphazoline—Sweating—Methotrexate—urinary bladder cancer	0.00355	0.00558	CcSEcCtD
Naphazoline—Hyperglycaemia—Epirubicin—urinary bladder cancer	0.00351	0.00551	CcSEcCtD
Naphazoline—Somnolence—Etoposide—urinary bladder cancer	0.00351	0.00551	CcSEcCtD
Naphazoline—Drowsiness—Epirubicin—urinary bladder cancer	0.00347	0.00545	CcSEcCtD
Naphazoline—Headache—Thiotepa—urinary bladder cancer	0.00344	0.00541	CcSEcCtD
Naphazoline—Sweating—Epirubicin—urinary bladder cancer	0.00332	0.00522	CcSEcCtD
Naphazoline—Asthenia—Gemcitabine—urinary bladder cancer	0.00331	0.00521	CcSEcCtD
Naphazoline—Nausea—Thiotepa—urinary bladder cancer	0.00326	0.00513	CcSEcCtD
Naphazoline—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.00325	0.0051	CcSEcCtD
Naphazoline—Drowsiness—Doxorubicin—urinary bladder cancer	0.00321	0.00504	CcSEcCtD
Naphazoline—Eye disorder—Methotrexate—urinary bladder cancer	0.00311	0.00489	CcSEcCtD
Naphazoline—Asthenia—Cisplatin—urinary bladder cancer	0.00309	0.00486	CcSEcCtD
Naphazoline—Sweating—Doxorubicin—urinary bladder cancer	0.00308	0.00483	CcSEcCtD
Naphazoline—Dizziness—Fluorouracil—urinary bladder cancer	0.003	0.00472	CcSEcCtD
Naphazoline—Eye disorder—Epirubicin—urinary bladder cancer	0.00291	0.00457	CcSEcCtD
Naphazoline—Erythema—Methotrexate—urinary bladder cancer	0.0029	0.00455	CcSEcCtD
Naphazoline—Headache—Gemcitabine—urinary bladder cancer	0.00289	0.00455	CcSEcCtD
Naphazoline—Headache—Fluorouracil—urinary bladder cancer	0.00285	0.00447	CcSEcCtD
Naphazoline—Asthenia—Etoposide—urinary bladder cancer	0.00283	0.00445	CcSEcCtD
Naphazoline—Nausea—Gemcitabine—urinary bladder cancer	0.00274	0.00431	CcSEcCtD
Naphazoline—Vision blurred—Methotrexate—urinary bladder cancer	0.00273	0.00429	CcSEcCtD
Naphazoline—Erythema—Epirubicin—urinary bladder cancer	0.00271	0.00426	CcSEcCtD
Naphazoline—Nausea—Fluorouracil—urinary bladder cancer	0.0027	0.00424	CcSEcCtD
Naphazoline—Eye disorder—Doxorubicin—urinary bladder cancer	0.00269	0.00423	CcSEcCtD
Naphazoline—Tension—Epirubicin—urinary bladder cancer	0.00266	0.00418	CcSEcCtD
Naphazoline—Nervousness—Epirubicin—urinary bladder cancer	0.00263	0.00414	CcSEcCtD
Naphazoline—Dizziness—Etoposide—urinary bladder cancer	0.00261	0.0041	CcSEcCtD
Naphazoline—Nausea—Cisplatin—urinary bladder cancer	0.00256	0.00402	CcSEcCtD
Naphazoline—Vision blurred—Epirubicin—urinary bladder cancer	0.00255	0.00401	CcSEcCtD
Naphazoline—Erythema—Doxorubicin—urinary bladder cancer	0.00251	0.00394	CcSEcCtD
Naphazoline—Headache—Etoposide—urinary bladder cancer	0.00247	0.00388	CcSEcCtD
Naphazoline—Tension—Doxorubicin—urinary bladder cancer	0.00246	0.00387	CcSEcCtD
Naphazoline—Discomfort—Methotrexate—urinary bladder cancer	0.00244	0.00383	CcSEcCtD
Naphazoline—Nervousness—Doxorubicin—urinary bladder cancer	0.00244	0.00383	CcSEcCtD
Naphazoline—Vision blurred—Doxorubicin—urinary bladder cancer	0.00236	0.00371	CcSEcCtD
Naphazoline—Nausea—Etoposide—urinary bladder cancer	0.00234	0.00368	CcSEcCtD
Naphazoline—Hypertension—Epirubicin—urinary bladder cancer	0.00234	0.00368	CcSEcCtD
Naphazoline—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.00228	0.00359	CcSEcCtD
Naphazoline—Discomfort—Epirubicin—urinary bladder cancer	0.00228	0.00358	CcSEcCtD
Naphazoline—Hypertension—Doxorubicin—urinary bladder cancer	0.00216	0.0034	CcSEcCtD
Naphazoline—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.00214	0.00336	CcSEcCtD
Naphazoline—Discomfort—Doxorubicin—urinary bladder cancer	0.00211	0.00331	CcSEcCtD
Naphazoline—Somnolence—Methotrexate—urinary bladder cancer	0.0021	0.0033	CcSEcCtD
Naphazoline—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.00198	0.00311	CcSEcCtD
Naphazoline—Somnolence—Epirubicin—urinary bladder cancer	0.00197	0.00309	CcSEcCtD
Naphazoline—Somnolence—Doxorubicin—urinary bladder cancer	0.00182	0.00286	CcSEcCtD
Naphazoline—Asthenia—Methotrexate—urinary bladder cancer	0.0017	0.00266	CcSEcCtD
Naphazoline—Asthenia—Epirubicin—urinary bladder cancer	0.00159	0.00249	CcSEcCtD
Naphazoline—Dizziness—Methotrexate—urinary bladder cancer	0.00156	0.00246	CcSEcCtD
Naphazoline—Headache—Methotrexate—urinary bladder cancer	0.00148	0.00233	CcSEcCtD
Naphazoline—Asthenia—Doxorubicin—urinary bladder cancer	0.00147	0.00231	CcSEcCtD
Naphazoline—Dizziness—Epirubicin—urinary bladder cancer	0.00146	0.0023	CcSEcCtD
Naphazoline—Nausea—Methotrexate—urinary bladder cancer	0.0014	0.00221	CcSEcCtD
Naphazoline—Headache—Epirubicin—urinary bladder cancer	0.00139	0.00218	CcSEcCtD
Naphazoline—Dizziness—Doxorubicin—urinary bladder cancer	0.00135	0.00213	CcSEcCtD
Naphazoline—Nausea—Epirubicin—urinary bladder cancer	0.00131	0.00206	CcSEcCtD
Naphazoline—Headache—Doxorubicin—urinary bladder cancer	0.00128	0.00201	CcSEcCtD
Naphazoline—Nausea—Doxorubicin—urinary bladder cancer	0.00122	0.00191	CcSEcCtD
